Nasopharyngeal carcinoma: Relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification

Nuclear Medicine Communications

Volumn 31, Issue 3, 2010, Pages 206-210

  Chan, Winnie K S ^a   Mak, Henry K F ^a   Huang, Bingsheng ^a   Yeung, David W C ^a   Kwong, Dora Lai Wan ^a   Khong, Pek Lan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

American Joint Committee on Cancer stages; Nasopharyngeal carcinoma; Positron emission tomography computed tomography; Standardized uptake value; Total lesion glycolysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; GLYCOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; GLYCOLYSIS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 76749122812     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328333e3ef     Document Type: Article

References (36)

1. Luo J, Chia KS, Chia SE, Reilly M, Tan SC, Ye W. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997. Eur J Epidemiol 2007; 22:513-521.
2. Chua DT, Sham JS, Wei WI, Ho WK, Au GK. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer 2001; 92:2845-2855.
3. Agulnik M, Siu LL. State-of-the-art management of nasopharyngeal carcinoma: current and future directions. Br J Cancer 2005; 92:799-806.
4. Wei WI, Mok VW. The management of neck metastases in nasopharyngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg 2007; 15:99-102.
5. Greene FL. AJCC cancer staging atlas. New York, NY: Springer; 2006.
6. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF, Changlai SP, et al., Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000; 109:1130-1134.
7. Liu FY, Lin CY, Chang JT, Ng SH, Chin SC,Wang HM, et al., 18F-FDG PET can replace conventional work-up in primary m staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med 2007; 48:1614-1619.
8. Yen RF, Hung RL, Pan MH, Wang KM, Lui LT, Kao CH. 18-fluoro-2- deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Cancer 2003; 98:283-287.
9. Gordin A, Golz A, Daitzchman M, Keidar Z, Bar-Shalom R, Kuten A, et al., Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management. Int J Radiat Oncol Biol Phys 2007; 68:370-376.
10. Chan SC, Chang JT,Wang HM, Lin CY, Ng SH, Fan KH, et al., Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value. Oral Oncol 2009; 45:52-58.
11. Lee SW, Nam SY, Im KC, Kim JS, Choi EK, Ahn SD, et al., Prediction of prognosis using standardized uptake value of 2-[18F] fluoro-2-deoxy-dglucose positron emission tomography for nasopharyngeal carcinomas. Radiother Oncol 2008; 87:211-216.
12. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al., Tumour treatment response based on visual and quantitative changes in global tumour glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Pos Img 1999; 2:159-171.
13. Chen MK, Chen TH, Liu JP, Chang CC, Chie WC. Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumour volume. Cancer 2004; 100:2160-2166.
14. Chu ST,Wu PH, Chou P, Lee CC. Primary tumour volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate. Eur Arch Otorhinolaryngol 2008; 265:115-120.
15. Lee CC, Chu ST, Ho HC, Lee CC, Hung SK. Primary tumour volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma. Acta Otolaryngol 2008; 128:93-97.
16. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, et al., Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003; 57:853-863.
17. Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, et al., Tumour volume in pharyngolaryngeal squamous cell carcinoma: comparison of CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004; 233:93-100.
18. Ma BB, King A, Dennis YM, Yau YY, Zee B, Hui EP, et al., Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumour burden, and metabolic activity in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006; 66:714-720.
19. Zheng XK, Chen LH, Wang QS, Wu HB, Wang HM, Chen YQ, et al., Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007; 69:1381-1388.
20. Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, et al., FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med 2003; 30:63-71.
21. Minn H, Lapela M, Klemi PJ, Grénman R, Leskinen S, Lindholm P, et al., Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997; 38:1907-1911.
22. Berkowitz A, Basu S, Srinivasa S, Sankaran S, Schuster S, Alavi A. Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose- PET. Nucl Med Commun 2008; 29:521-526.
23. Chong VF, Zhou JY, Khoo JB, Chan KL, Huang J. Correlation between MR imaging-derived nasopharyngeal carcinoma tumour volume and TNM system. Int J Radiat Oncol Biol Phys 2006; 64:72-76.
24. Zhou JY, Chong VF, Khoo JB, Chan KL, Huang J. The relationship between nasopharyngeal carcinoma tumour volume and TNM T-classification: a quantitative analysis. Eur Arch Otorhinolaryngol 2007; 264:169-174.
25. Burri RJ, Rangaswamy B, Kostakoglu L, Hoch B, Genden EM, Som PM, et al., Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck. Int J Radiat Oncol Biol Phys 2008; 71:682-688.
26. Weber AL, Arayedh SA, Rashid A. Nasopharynx: clinical, pathologic, and radiologic assessment. Neuroimag Clin N Am 2003; 13:465-483.
27. Ruoslahti E. How cancer spreads. Sci Am 1996; 275:72-77.
28. Folkman J. Clinical application of research on angiogenesis. N Engl J Med 1995; 333:1757-1763.
29. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer 2003; 98:413-423.
30. Shayan R, Achen MG, Stacker SA. Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 2006; 27:1729-1738.
31. MacDonald IC, Groom AC, Chambers AF. Cancer spread and micrometastasis development: quantitative approaches for in vivo models. BioEssays 2002; 24:885-893.
32. Meng X, Yu J, Liu S, Li J, Fu Z, Sun X, et al., Pretreatment F-18 fluorodeoxyglucose-positron emission tomography standardized uptake value predicts survival after radiation therapy in nasopharyngeal carcinoma (Meeting Abstract). Int J Radiat Oncol Biol Phys 2007; 69:S442-S443.
33. Sze WM, Lee AW, Yau TK, Yeung RM, Lau KY, Leung SK, et al., Primary tumour volume of nasopharyngeal carcinoma: prognostic significance for local control. Int J Radiat Oncol Biol Phys 2004; 59:21-27.
34. Roedl JB, Colen RR, Holalkere NS, Fischman AJ, Choi NC, Blake MA. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumour volume as measured on PET-CT Comparison to histopathologic and clinical response evaluation. Radiother Oncol 2008; 89:278-286.
35. Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, et al., Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 2004; 199:1-7.
36. Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, et al., 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med 2009; 50:340-347.